How Pharmaceutical Incumbents Stifle Innovation and Inhibit Disruptors
Alex, Nick, and guest speaker D.A. Wallach discuss some of the disreputable ways incumbents in the pharmaceutical industry stifle innovation and inhibit disruptors. They go over methods including cutting off data flows and wielding the leverage of negotiated pricing across large portfolios.
Life Sciences Investor D.A. Wallach Interview: youtu.be/7BHofAqxn9c
Filed under: Winner Take All | Topics:
Top Posts
-
![]()
B2B Chemical Marketplaces and Tech Startups: Landscape and State of the Industry
-
![]()
Platform vs. Linear: Business Models 101
-
![]()
Amazon Business – 2020 Report
-
![]()
Platform Business Model – Definition | What is it? | Explanation
-
![]()
The Value of Digital Transformation: How Investors Evaluate “Tech”
Related Articles
Category
Winner Take All
